CrushSCI.com
提供学术论文选刊润色服务
Molecular Cancer 期刊封面 医学
返回期刊列表

Review Cycle Records

Molecular Cancer

Springer SCIE OA
2026新锐 1区2025中科院 1区 TOP2025 JCR Q1
102.8平均天数
94中位天数
36最短天数
202最长天数
3322025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

64 天

Advances in improving cancer immunotherapy with nanotechnology: from smart nanoparticles to synergistic combination strategies

作者Untack Cho; Jingjing Pu; Amit Sharma; Junhyuk Song; Ji Hyeon You; Yona Kim; Pyung Won Im; Hyung Woo Park; Hyo Eun Moon; Ho Sung Myeong; Hye Ran Park; Jian Hou; Ingo G. H. Schmidt-Wolf; Sun Ha Paek

作者单位1. Department of Neurosurgery, Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea; 2. Department of Life and Chemical Engineering, Gyeonggi University of Science and Technology, Siheung, Korea; 3. Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 4. Department of Integrated Oncology, Center for Integrated Oncology (CIO) Bonn, University Hospital Bonn, Bonn, Germany; 5. Department of Neurosurgery, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea; 6. Advanced Institute of Convergence Technology, Seoul National University, Suwon, Korea

PDF源文件 DOI 网页
93 天

Mutation-specific dynamics of dedifferentiation trajectories and tumor–stromal interactions in thyroid cancer

作者Eun Hye Joo; Young Shin Song; Han Sai Lee; Gyeongseo Jung; Eun-jae Chung; Su-jin Kim; Yoo Hyung Kim; Sun Wook Cho; Hongyoon Choi; Jae-kyung Won; Woong-Yang Park; Young Joo Park

作者单位1. Genomic Medicine Institute Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea; 2. Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea; 3. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; 4. Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea; 5. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; 6. Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea; 7. Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea; 8. Department of Surgery, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea; 9. Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; 10. Department of Pathology, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea; 11. Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea

PDF源文件 DOI 网页
146 天

Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer

作者Chunbo He; Dezhen Wang; Tuo Hu; Daisy Gonzalez; Ravi Thakur; Damian P. Matysniak; Ryan J. King; Sai Sundeep Kollala; Spas Dimitrov Markov; Yuki Fujii; Gullanki Naga Venkata Charan Tej; Junzhang Zhao; Longyang Jin; Rebecca Oberley-Deegan; Surendra K. Shukla; Xin A. Zhang; Jacob E. Friedman; Pankaj K. Singh; Michael A. Hollingsworth; Marina Pasca di Magliano; Howard C. Crawford; Kamiya Mehla

作者单位1. Department of Oncology Science, University of Oklahoma Health Campus, Oklahoma City, USA; 2. Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA; 3. Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, USA; 4. OU Health Stephenson Cancer Center, University of Oklahoma Health Campus, Oklahoma City, USA; 5. Department of Biochemistry and Physiology, University of Oklahoma Health Campus, Oklahoma City, USA; 6. Harold Hamm Diabetes Center, University of Oklahoma Health Campus, Oklahoma City, USA; 7. Department of Surgery, University of Michigan, Ann Arbor, USA; 8. Department of Pharmacology and Toxicology, Michigan State University, Lansing, USA; 9. Department of Surgery, Henry Ford Health System, Detroit, USA; 10. Department of Microbiology and Immunology, University of Oklahoma Health Campus, Oklahoma City, USA; 11. Department of Pathology, University of Oklahoma Health Campus, Oklahoma City, USA

PDF源文件 DOI 网页
100 天

IL-17–driven tumor cell–intrinsic inflammatory programming creates an immunotherapy-permissive microenvironment

作者Kosuke Murakami; Shiki Takamura; Chiho Miyagawa; Shiro Takamatsu; Yoko Kashima; Koji Nagaoka; Yukari Kobayashi; Yoshiyuki Hakata; Shigeki Kato; Sachiyo Tsuji-Kawahara; Ding Nan; Ronald Chandler; Satoru Takahashi; Masaaki Miyazawa; Kazuhiro Kakimi; Noriomi Matsumura

作者单位1. Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Sakai, Japan; 2. Laboratory for Immunological Memory, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; 3. Department of Immunology, Kindai University Faculty of Medicine, Sakai, Japan; 4. Department of Arts and Sciences, Kindai University Faculty of Medicine, Sakai, Japan; 5. Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, East Lansing, USA; 6. Department of Anatomy and Embryology and Laboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine, University of Tsukuba, Tsukuba, Japan

PDF源文件 DOI 网页
84 天

Deconstructing cancer in 3D: models, mechanisms, and personalized solutions

作者Zhao Huang; Xirui Duan; Jun Ji; Qu Cai; Ping Jin; Beiqin Yu; Jun Zhang

作者单位1. West China Institute of Preventive and Medical Integration for Major Diseases, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China; 2. Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 3. Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 4. State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan and Key Laboratory of Industrial Microbial Fermentation Engineering of Yunnan Province, School of Life Sciences, Yunnan University, Kunming, China; 5. Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 6. Shanghai Key Laboratory of Gastric Neoplasms, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

PDF源文件 DOI 网页
123 天

Insight of immune checkpoint blockades in melanoma: mechanism and clinical translation

作者Qingyan Zhang; Chunhui Yuan; Lin Zhu; Shaobing Zheng; Yantao Xu; Xuanlin Che; Shiyu Xiao; Juan Liu; Hong Liu; Hui Li; Xiang Chen

作者单位1. The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China; 2. National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; 3. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China; 4. Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; 5. National Medical Metabolomics International Collaborative Research Center, Xiangya Hospital, Central South University, Changsha, China; 6. Furong Laboratory, Changsha, China; 7. Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China

PDF源文件 DOI 网页
36 天

Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation

作者Junzhi Liu; Xiaoyu Zuo; Xue Yang; Xinyue Wang; Lu Gan; Jianxin Xue

作者单位1. Division of Thoracic Tumour Multimodality Treatment, Cancer Center & State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China; 2. Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China; 3. Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China; 4. Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China; 5. Laboratory of Clinical Cell Therapy, West China Hospital, Sichuan University, Chengdu, China

PDF源文件 DOI 网页
85 天

Histone modifications across cancers: mechanisms, therapy and clinical translation

作者Pengde Lu; Yau-Tuen Chan; Chun-Fung Kwok; Qiucheng Li; Zhuofeng Jiang; Lin Xu; Zixin Feng; Hongchao Yuan; Jiaqi Zou; Yunqing Xun; Tung-Leong Fong; Chi-Ming Che; Ning Wang

作者单位1. School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong S.A.R.,, P. R. China; 2. State Key Laboratory of Synthetic Chemistry, Department of Chemistry, The University of Hong Kong, Hong Kong, China; 3. Laboratory for Synthetic Chemistry and Chemical Biology Limited, Hong Kong Science Park, Hong Kong

PDF源文件 DOI 网页
202 天

Navigating luminal heterogeneity: etiology-based proteogenomic subtyping for targeted treatment strategies in breast cancer

作者Ya-Hsuan Chang; Yi-Ju Chen; Zhi-Jie Hong; Yi-Jing Hsiao; Kuen-Tyng Lin; Guo-Shiou Liao; Sheng-Fang Su; Ze-Shiang Lin; Huei-Wen Chen; Chia-Li Han; Eric Sheng-Wen Chen; Yin-Chen Hsu; Yan-Ming Chen; Hao Fang; Hao-Chin Yang; Yan-Si Chen; Chien-Yu Lin; Hsiang-En Hsu; Ching-Hung Lin; Pin-Lian Jiang; Pei-Shan Wu; Ching-Wen Chen; Chen-Ting Hung; Ethan Wu; Wei-Tzu Chiu; Fan-Ni Hsing; Tsai-Pei Liu; Chia-Yu Wang; Yu-Tai Wang; Chang-Wei Yeh; Ki-Hok Liao; Ana I Robles; Henry Rodriguez; Show-Ling Yang; Mien-Chie Hung; Yen-Shen Lu; Hsuan-Yu Chen; Sung-Liang Yu; Jyh-Cherng Yu; Yu-Ju Chen

作者单位1. Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan; 2. Institute of Statistical Science, Academia Sinica, Taipei, Taiwan; 3. Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; 4. Institute of Chemistry, Academia Sinica, Taipei, Taiwan; 5. Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan; 6. Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan; 7. Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan; 8. Graduate Institute of Toxicology, National Taiwan University College of Medicine, Taipei, Taiwan; 9. Master Program in Clinical Genomics and Proteomics, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; 10. Department of Medical Oncology, Cancer Center Branch, National Taiwan University Hospital, Taipei, Taiwan; 11. Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; 12. Department of Chemistry, National Taiwan University, Taipei, Taiwan; 13. National Center for High-performance Computing, National Institutes of Applied Research, Hsinchu, Taiwan; 14. Office of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Rockville, USA; 15. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; 16. Graduate Institute of Biomedical Sciences, Cancer Biology and Precision Therapeutics Center, Center for Molecular Medicine, China Medical University, Taichung, Taiwan; 17. Ph.D. Program in Microbial Genomics, National Chung Hsing University, Taichung, Taiwan; 18. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan

PDF源文件 DOI 网页
95 天

Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma

作者Fanhong Zeng; Jiaxin Guo; Zheng Zeng; Vanilla Xin Zhang; Yu-Man Tsui; Po-Man Li; Abdullah Husain; Qingyang Zhang; Joyce Man-Fong Lee; Tan-To Cheung; Daniel Wai-Hung Ho; Irene Oi-Lin Ng

作者单位1. Department of Pathology, The University of Hong Kong, Hong Kong, China; 2. State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China; 3. Department of Surgery, The University of Hong Kong, Hong Kong, China

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。